Chronic myelomonocytic leukemia
Chronic Myelomonocytic Leukemia (kron-ik my-elo-mono-sit-ik loo-kee-mee-uh) is a rare type of cancer that affects the blood cells and bone marrow. The disease is characterized by an increase in the number of both myeloid cells and monocytes in the blood.
Etymology
The term "Chronic Myelomonocytic Leukemia" is derived from the Greek words "chronos" (time), "myelos" (marrow), "monos" (single), and "cyte" (cell). The term "leukemia" is derived from the Greek words "leukos" (white) and "haima" (blood).
Symptoms
Symptoms of Chronic Myelomonocytic Leukemia may include fatigue, fever, weight loss, and infections. Some patients may also experience anemia, thrombocytopenia, and neutropenia.
Diagnosis
Diagnosis of Chronic Myelomonocytic Leukemia typically involves a complete blood count (CBC), bone marrow biopsy, and cytogenetic analysis.
Treatment
Treatment options for Chronic Myelomonocytic Leukemia may include chemotherapy, stem cell transplant, and supportive care such as blood transfusions and antibiotics.
Prognosis
The prognosis for Chronic Myelomonocytic Leukemia varies depending on factors such as the patient's age, overall health, and the specific characteristics of their leukemia.
See also
External links
- Medical encyclopedia article on Chronic myelomonocytic leukemia
- Wikipedia's article - Chronic myelomonocytic leukemia
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski